The SNARE proteins syntaxin, SNAP-25, and synaptobrevin play a central role during Ca(2+)-dependent exocytosis at the nerve terminal. Whereas syntaxin and SNAP-25 are located in the plasma membrane, synaptobrevin resides in the membrane of synaptic vesicles. It is thought that gradual assembly of these proteins into a membrane-bridging ternary SNARE complex ultimately leads to membrane fusion. ...

Tartrate-resistant acid phosphatase (TRAcP) has been an indispensible marker for hairy cell eukemia (HCL) for over two decades. However, the traditional TRAcP cytochemical stain cannot be performed effectively on sections of paraffin-embedded tissues that are important resources for histopathologic evaluation in diagnosis and treatment of HCL. Wide variation in expression of TRAcP activity by h...

EVERY NEWLY elected official has his "probationary" period. There is a short season of luckwishing, f ront running, and freedom from critictsm and carping. Politicians who had oppo.sed the winnnig candidate now come grinning and fawning; newspapers ' had lashed him now find in h i m ' fual i t ies t ha t have miraculously •merged since the ballot box rej tu rns ; the pubhc, tolerant and hopeful...

A new asymptotic expansion method is developed to separate the WheelerDeWitt equation into the time-dependent Schrödinger equation for a matter field and the Einstein-Hamilton-Jacobi equation for the gravitational field including the quantum back-reaction of the matter field. In particular, the nonadiabatic basis of the generalized invariant for the matter field Hamiltonian separates the Wheele...

Rapid neurotransmitter release depends on the ability to arrest the SNAP receptor (SNARE)-dependent exocytosis pathway at an intermediate "cocked" state, from which fusion can be triggered by Ca(2+). It is not clear whether this state includes assembly of synaptobrevin (the vesicle membrane SNARE) to the syntaxin-SNAP-25 (target membrane SNAREs) acceptor complex or whether the reaction is arres...

The M1 muscarine agonist, 5-(2-ethyl-2H-tetrazol-5-yl)-1-methyl-1,2, 3,6-tetrahydropyridine (Lu 25-109), is extensively metabolized in mice, rats, dogs, and humans. The metabolite profile after an oral dose of [(14)C]Lu 25-109 was determined in plasma and in urine. Lu 25-109 was metabolized by N-demethylation (Lu 25-077), N-oxidation (Lu 32-181), and N-deethylation (Lu 31-126). In addition, com...